Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MG132
i
Other names:
MG132, MG-132
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Dorothy M. Davis Heart and Lung Research Institute, Jilin University
Drug class:
Proteasome inhibitor
Related drugs:
‹
bortezomib (90)
ixazomib (31)
carfilzomib (18)
NPI-0052 (2)
AVA3996 (0)
CEP-18770 (0)
ONX 0912 (0)
bortezomib (90)
ixazomib (31)
carfilzomib (18)
NPI-0052 (2)
AVA3996 (0)
CEP-18770 (0)
ONX 0912 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MET overexpression
Non Small Cell Lung Cancer
MET overexpression
Non Small Cell Lung Cancer
MG132
Sensitive: D – Preclinical
MG132
Sensitive
:
D
MG132
Sensitive: D – Preclinical
MG132
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login